Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptors lysophosphatidic acid
Most Correlated Studies
- Endometrial cells treated with lysophosphatidic acid (LPA) and interferon tau (IFNt)
- Breast and prostate cancer cell lines treated with lysophosphatidic acid
- Mammary tumors from mice overexpressing ATX, LPA1, LPA2, or LPA3 in mammary epithelium
- Prostate carcinoma PC-3M cells with siRNA knockdown of lysine-specific demethylase 1 (LSD1)
Most Relevant Literature
- Current progress in non-Edg family LPA receptor research.
- Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
- Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
- Lateral access mechanism of LPA receptor probed by molecular dynamics simulation.
- First-in-class antifibrotic therapy targeting type 1 lysophosphatidic acid receptor.
Most Relevant Clinical Trials
- Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
- To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Posi…
- Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment
- Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327
- Proof of Biological Activity of SAR100842 in Systemic Sclerosis
